{"entity":{"type":"insider","cik":"0001508052","url":"/insider/0001508052","json_url":"/insider/0001508052.json","name":"Flagship Ventures Fund 2007, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":10,"first":"2013-03-27","last":"2019-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Flagship Ventures Fund 2007, L.P.","source":"filing","n_filings":10,"first_seen":"2013-03-27","last_seen":"2019-05-15"}],"transactions":[{"id":8667371,"accession":"0001104659-19-029735","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001104659-19-029735","line_url":"/filing/0001104659-19-029735#line-12","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; Flagship Ventures Opportunities Fund I, L.P.; AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship VentureLabs IV, LLC; KANIA EDWIN M JR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":986023.0,"shares_owned_after_display":"986,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":2163644,"accession":"0001012975-16-001507","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001012975-16-001507","line_url":"/filing/0001012975-16-001507","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV-Rx, L.P.; Flagship Ventures Fund IV, L.P.","owner_display_name":"Flagship Ventures Fund 2007, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67071.0,"shares_display":"67,071","price_per_share":3.1139553607371293,"price_display":"3.11","price_state":"stated","total_value":208856.1,"total_display":"208,856.10","total_whole":"208,856","shares_owned_after":426885.0,"shares_owned_after_display":"426,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-23","filed_date":"2016-09-26","scope":"insider","n_lines":4},{"id":2163624,"accession":"0001012975-16-001507","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-16-001507","line_url":"/filing/0001012975-16-001507","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV-Rx, L.P.; Flagship Ventures Fund IV, L.P.","owner_display_name":"Flagship Ventures Fund 2007, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":376351.0,"shares_display":"376,351","price_per_share":3.1737436860802815,"price_display":"3.17","price_state":"stated","total_value":1194441.61,"total_display":"1,194,441.61","total_whole":"1,194,442","shares_owned_after":480545.0,"shares_owned_after_display":"480,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-22","filed_date":"2016-09-26","scope":"insider","n_lines":4},{"id":2588132,"accession":"0001012975-16-001505","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-16-001505","line_url":"/filing/0001012975-16-001505","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":322723.0,"shares_display":"322,723","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":1210211.25,"total_display":"1,210,211.25","total_whole":"1,210,211","shares_owned_after":781643.0,"shares_owned_after_display":"781,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-21","filed_date":"2016-09-21","scope":"insider","n_lines":2},{"id":2588123,"accession":"0001012975-16-001505","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-16-001505","line_url":"/filing/0001012975-16-001505","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53917.0,"shares_display":"53,917","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":182778.63,"total_display":"182,778.63","total_whole":"182,779","shares_owned_after":1039857.0,"shares_owned_after_display":"1,039,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-21","scope":"insider","n_lines":2},{"id":2588113,"accession":"0001012975-16-001505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-001505","line_url":"/filing/0001012975-16-001505","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":3.31,"price_display":"3.31","price_state":"stated","total_value":32107.0,"total_display":"32,107.00","total_whole":"32,107","shares_owned_after":1082996.0,"shares_owned_after_display":"1,082,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-21","scope":"insider","n_lines":2},{"id":3161028,"accession":"0001012975-16-001503","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-16-001503","line_url":"/filing/0001012975-16-001503","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2681.0,"shares_display":"2,681","price_per_share":4.16,"price_display":"4.16","price_state":"stated","total_value":11152.96,"total_display":"11,152.96","total_whole":"11,153","shares_owned_after":1090757.0,"shares_owned_after_display":"1,090,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-16","scope":"insider","n_lines":2},{"id":3161021,"accession":"0001012975-16-001503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-001503","line_url":"/filing/0001012975-16-001503","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44011.0,"shares_display":"44,011","price_per_share":4.18,"price_display":"4.18","price_state":"stated","total_value":183965.98,"total_display":"183,965.98","total_whole":"183,966","shares_owned_after":1092902.0,"shares_owned_after_display":"1,092,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-16","scope":"insider","n_lines":2},{"id":3161011,"accession":"0001012975-16-001495","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-16-001495","line_url":"/filing/0001012975-16-001495","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; AFEYAN NOUBAR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93727.0,"shares_display":"93,727","price_per_share":4.51,"price_display":"4.51","price_state":"stated","total_value":422708.77,"total_display":"422,708.77","total_whole":"422,709","shares_owned_after":1833802.0,"shares_owned_after_display":"1,833,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-07","filed_date":"2016-09-08","scope":"insider","n_lines":3},{"id":3161000,"accession":"0001012975-16-001495","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-001495","line_url":"/filing/0001012975-16-001495","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; AFEYAN NOUBAR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35770.0,"shares_display":"35,770","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":165615.1,"total_display":"165,615.10","total_whole":"165,615","shares_owned_after":1886787.0,"shares_owned_after_display":"1,886,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-08","scope":"insider","n_lines":3},{"id":3109103,"accession":"0001012975-16-001264","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001012975-16-001264","line_url":"/filing/0001012975-16-001264","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR; Flagship VentureLabs IV, LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR","owner_display_name":"Flagship Ventures Fund 2007, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":27.6,"price_display":"27.60","price_state":"stated","total_value":27600000.0,"total_display":"27,600,000.00","total_whole":"27,600,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-27","scope":"insider","n_lines":3},{"id":6749253,"accession":"0001181431-14-006845","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-006845","line_url":"/filing/0001181431-14-006845","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.; Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR","owner_display_name":"Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":378729.0,"shares_display":"378,729","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3787290.0,"total_display":"3,787,290.00","total_whole":"3,787,290","shares_owned_after":1907008.0,"shares_owned_after_display":"1,907,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-11","filed_date":"2014-02-13","scope":"insider","n_lines":3},{"id":5331553,"accession":"0001181431-13-059544","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-059544","line_url":"/filing/0001181431-13-059544#line-4","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund 2007, L.P.","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20300.0,"shares_display":"20,300","price_per_share":24.09,"price_display":"24.09","price_state":"stated","total_value":489027.0,"total_display":"489,027.00","total_whole":"489,027","shares_owned_after":1693551.0,"shares_owned_after_display":"1,693,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-18","scope":"insider"},{"id":5331550,"accession":"0001181431-13-059544","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-059544","line_url":"/filing/0001181431-13-059544","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund 2007, L.P.","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54904.0,"shares_display":"54,904","price_per_share":24.214818592452282,"price_display":"24.21","price_state":"stated","total_value":1329490.4,"total_display":"1,329,490.40","total_whole":"1,329,490","shares_owned_after":1714755.0,"shares_owned_after_display":"1,714,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider","n_lines":2},{"id":5331542,"accession":"0001181431-13-059544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-059544","line_url":"/filing/0001181431-13-059544#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund 2007, L.P.","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155583.0,"shares_display":"155,583","price_per_share":25.03,"price_display":"25.03","price_state":"stated","total_value":3894242.49,"total_display":"3,894,242.49","total_whole":"3,894,242","shares_owned_after":1768755.0,"shares_owned_after_display":"1,768,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-14","filed_date":"2013-11-18","scope":"insider"},{"id":4959681,"accession":"0001104659-13-041517","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-13-041517","line_url":"/filing/0001104659-13-041517#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures 2007 General Partner LLC; KANIA EDWIN M JR; AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.","owner_display_name":"Flagship Ventures 2007 General Partner LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":107142.0,"shares_display":"107,142","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1499988.0,"total_display":"1,499,988.00","total_whole":"1,499,988","shares_owned_after":1924339.0,"shares_owned_after_display":"1,924,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-14","scope":"insider"},{"id":5524883,"accession":"0001181431-13-019227","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-13-019227","line_url":"/filing/0001181431-13-019227#line-6","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2004 L P; KANIA EDWIN M JR; Flagship Ventures General Partner LLC; Flagship Ventures 2007 General Partner LLC; AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.","owner_display_name":"Flagship Ventures Fund 2004 L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":491824.0,"shares_display":"491,824","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3442768.0,"total_display":"3,442,768.00","total_whole":"3,442,768","shares_owned_after":1165786.0,"shares_owned_after_display":"1,165,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-03-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001633070","name":"Axcella Health Inc.","url":"/issuer/0001633070","role":"Ten percent owner","n_filings":1,"first_seen":"2019-05-15","last_seen":"2019-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001485003","name":"Eleven Biotherapeutics, Inc.","url":"/issuer/0001485003","role":"Ten percent owner","n_filings":5,"first_seen":"2014-02-13","last_seen":"2016-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001609809","name":"Seres Therapeutics, Inc.","url":"/issuer/0001609809","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-27","last_seen":"2016-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001463729","name":"Receptos, Inc.","url":"/issuer/0001463729","role":"Ten percent owner","n_filings":2,"first_seen":"2013-05-14","last_seen":"2013-11-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Ten percent owner","n_filings":1,"first_seen":"2013-03-27","last_seen":"2013-03-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001508052","retrieved_at":"2026-08-23T02:36:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}